All In MedTech

Device Trial Radar · NCT04531293

Comparing Pressure Based and Dilution Based Total Lung Capacity Measurements in COPD Patients for Lung Function Diagnostics

Mono-centred, Controlled Cross-over Study Comparing Pressure Based, and Dilution Based Total Lung Capacity Measurements in COPD Patients and Healthy Subjects Using Two Commercially Available Devices for Lung Function Diagnostics

Last checked: Nov 19, 2026Latest source record: Jun 6, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

128

Actual

Start

Dec 31, 2020

Primary completion

Apr 11, 2022

Study completion Apr 11, 2022

Sponsor

Lead sponsor
ndd Medizintechnik AGNot on our public-company list
Sponsor type
Industry
First posted
Aug 28, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Crossover
Masking
None
Primary purpose
Other
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Total Lung Capacity (TLC) of the lungs can be determined using a pressure based method (i.e. by body plethysmography) or it can be determined using a dilution based method (i.e. by single breath dilution during a CO diffusing capacity test). The results of the two methods differ, especially in patients with higher grades of COPD. The study investigates an improved analysis for the determination of TLC using the dilution method; this method has been suggested in the new ATS/ERS DLCO (diffusion capacity of lung for carbon monoxide) standard published in 2017. This study is based on approx. 120 participants. So far, there has not been a study using commercially available equipment. Spirometry, lung volume measurement by body plethysmography and DLCO measurements will be performed on reference device (Masterscreen Body/Diff, Vyaire, USA), Spirometry and DLCO will also be performed on the device under test (EasyOne Pro LAB, ndd Medizintechnik AG, Switzerland) in a crossover design. Both devices are CE marked and FDA approved. The tests performed on both devices are standardized tests performed routinely with patients.

Conditions

  • COPD

Interventions

  • Respiratory Analysis SystemDevice

    Measurement of total lung capacity using total-breath method

  • Respiratory Analysis SystemDevice

    Measurement of total lung capacity using standard method

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Comparison of Total Lung Capacity (TLC) measurement using total-breath method and standard methodTime frame: single measurement on day 1

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • LungenZentrum Hirslanden

    Zurich, Switzerland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.